ymjЯкутский медицинский журналYakut Medical Journal1813-19052312-1017ЯНЦ КМП10.25789/YMJ.2022.79.17ymj-83Research ArticleАКТУАЛЬНАЯ ТЕМАACTUAL TOPICОценка уровня мелатонина после COVID-19 у жителей г. ЯкутскаEvaluation of melatonin levels after COVID-19 in Yakutsk residentsГригорьеваА. А.GrigorievaA. A.

Григорьева Анастасия Анатольевна – м.н.с., Арктический медицинский центр

Grigorieva Anastasia Anatolyevna – MD, Arctic Medical Center

nastiagrigoryeva@gmail.comОхлопковаЕ. Д.OkhlopkovaE. D.

Охлопкова Елена Дмитриевна – к.б.н., с.н.с.

Okhlopkova Elena Dmitrievna – Ph.D of Biology, senior researcher

ОлесоваЛ. Д.OlesovaL. D.

Олесова Любовь Дыгыновна – к.б.н., в.н.с.зав. лаб.

Olesova Lyubov Dygynovna – PhD of Biology, visiting research fellow, head of the Lab

ЕфремоваС. Д.EfremovaS. D.

Ефремова Светлана Дмитриевна – м.н.с.

Efremova Svetlana Dmitrievna – junior researcher                             

ФГБНУ «ЯНЦ КМП»РоссияFBSI Yakut Sscientific Centre of Complex Medical ProblemsRussian Federation202203022025036568Copyright © Григорьева А.А., Охлопкова Е.Д., Олесова Л.Д., Ефремова С.Д., 20252025Григорьева А.А., Охлопкова Е.Д., Олесова Л.Д., Ефремова С.Д.Grigorieva A.A., Okhlopkova E.D., Olesova L.D., Efremova S.D.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://ymj.elpub.ru/jour/article/view/83

В статье приведены результаты оценки уровня мелатонина после COVID-19 у жителей г. Якутска. Выявлено, что после перенесенной коронавирусной инфекции идет снижение уровня мелатонина. Коронавирусная инфекция влияет на выработку мелатонина, что впоследствии приводит к нарушению ритмов жизнедеятельности.

The article presents the results of assessing the level of melatonin after Covid-19 in residents of Yakutsk. It was found that after the coronavirus infection, there is a decrease in the level of melatonin. Coronavirus infection affects the production of melatonin, which subsequently leads to disruption of vital rhythms.

мелатонинCovid-19тревогадепрессиябессонницаmelatoninCovid-19anxietydepressioninsomnia.ReferencesБерезова Д.Т. Мелатонин: свойства, биоритмы и возможности использования в медицине/ Березова Д.Т. // Владикавказский медико-биологический вестник. – 2012. – № 23. – С. 127-133. Berezova D.T. Melatonin: properties, biorhythms and possibilities of use in medicine/ Berezova D.T. // Vladikavkaz medical and biological bulletin. - 2012. - 23. - P. 127-133.Berezova D.T. Melatonin: properties, biorhythms and possibilities of use in medicine/ Berezova D.T. // Vladikavkaz medical and biological bulletin. - 2012. - 23. - P. 127-133.Данилов А.Б. Мелатонин – уникальная молекула? / А.Б. Данилов, Ю.М. Курганов // Эффективная фармакотерапия. Неврология и психиатрия. ˗ 2013. ˗ № 1. ˗ С. 26-30. Danilov A.B. Melatonin is a unique molecule? / A.B. Danilov, Yu.M. Kurganov // Effective pharmacotherapy. Neurology and psychiatry. 2013. – No. 1. - P. 26-30.Danilov A.B. Melatonin is a unique molecule? / A.B. Danilov, Yu.M. Kurganov // Effective pharmacotherapy. Neurology and psychiatry. 2013. – No. 1. - P. 26-30.М.В. Тардов. Бессонница при covid-19 / М.В. Тардов, М.Г. Полуэктов // Эффективная фармакотерапия. - 2021. - Том: 17 №33. –С.36- 41. doi: 10.33978/2307-3586-2021-17-33-36-41.M.V. Tardov. Insomnia at Covid-19 / M.V. Tardov, M.G. Semiectov // Effective pharmacotherapy. - 2021. - Volume: 17 33. - P. 36-41. doi: 10.33978/2307-3586-2021-17-33-36-41.Anderson G. Melatonin: roles in influenza, Covid-19, and other viral infections. / G. Anderson, RJ. Reiter. // Rev Med Virol. (2020) May;30(3):e2109. doi: 10.1002/rmv.2109.Anderson G. Melatonin: roles in influenza, Covid-19, and other viral infections. / G. Anderson, RJ. Reiter. // Rev Med Virol. (2020) May;30(3):e2109. doi: 10.1002/rmv.2109.Abdelhady A. COVID-19-associated sleep disorders: A case report // Neurobiol Sleep Circadian Rhythms. 2020. Vol. 9, no. 2. P. 3–5. DOI: 10.1016/j.nbscr.2020.100057.Abdelhady A. COVID-19-associated sleep disorders: A case report // Neurobiol Sleep Circadian Rhythms. 2020. Vol. 9, no. 2. P. 3–5. DOI: 10.1016/j.nbscr.2020.100057.Asmundson G.J. Coronaphobia: Fear and the 2019-nCoV outbreak / G.J. Asmundson, S. Taylor // Journal of Anxiety Disorders. 2020. Vol. 70. Р. 10–21. DOI: 10.1016/j.janxdis.2020.102196.Asmundson G.J. Coronaphobia: Fear and the 2019-nCoV outbreak / G.J. Asmundson, S. Taylor // Journal of Anxiety Disorders. 2020. Vol. 70. Р. 10–21. DOI: 10.1016/j.janxdis.2020.102196.A review of sleep disorders and melatonin / Z. Xie, F. Chen, A. Li William, et al. // A Journal of Progress in Neurosurgery, Neurology and Neurosciences Volume 39, 2017 - Issue Pages 559-565 doi.org/10.1080/01616412.2017.1315864A review of sleep disorders and melatonin / Z. Xie, F. Chen, A. Li William, et al. // A Journal of Progress in Neurosurgery, Neurology and Neurosciences Volume 39, 2017 - Issue Pages 559-565 doi.org/10.1080/01616412.2017.1315864Besedovsky L. The sleep-immune crosstalk in health and disease / L. Besedovsky, T. Lange, M. Haack // Physiol. Rev. 2019. Vol. 99, No. 10. Р. 1325–1380. DOI: 10.1152/physrev.00010.2018Besedovsky L. The sleep-immune crosstalk in health and disease / L. Besedovsky, T. Lange, M. Haack // Physiol. Rev. 2019. Vol. 99, No. 10. Р. 1325–1380. DOI: 10.1152/physrev.00010.2018Infections, pandemics and sleep disorders / O.V. Kolokolov, E.A.Salina, V.V. Yudina, A.A. et al. // Zh Nevrol Psikhiatr Im S.S. Korsakova. 2021;121(4. Vyp. 2): p. 68-74. doi: 10.17116/jnevro202112104268Infections, pandemics and sleep disorders / O.V. Kolokolov, E.A.Salina, V.V. Yudina, A.A. et al. // Zh Nevrol Psikhiatr Im S.S. Korsakova. 2021;121(4. Vyp. 2): p. 68-74. doi: 10.17116/jnevro202112104268Ibarra-Coronado E.G. The Bidirectional Relationship between Sleep and Immunity against Infections. / E.G. Ibarra-Coronado, A.M. Pantaleón-Martínez // J. Immunol Res. 2015. Vol. 3, no. 1. Р. 67–75. DOI: 10.1155/2015/678164Ibarra-Coronado E.G. The Bidirectional Relationship between Sleep and Immunity against Infections. / E.G. Ibarra-Coronado, A.M. Pantaleón-Martínez // J. Immunol Res. 2015. Vol. 3, no. 1. Р. 67–75. DOI: 10.1155/2015/678164Jarrott B. “LONG COVID”—A hypothesis forunderstanding the biological basis and pharmacological treatment strategy. / B. Jarrott, R. Head, KG. Pringle, et al. // Pharmacol Res Perspect. 2022;10:e00911. doi:10.1002/prp2.911Jarrott B. “LONG COVID”—A hypothesis forunderstanding the biological basis and pharmacological treatment strategy. / B. Jarrott, R. Head, KG. Pringle, et al. // Pharmacol Res Perspect. 2022;10:e00911. doi:10.1002/prp2.911Melatonin effects on sleep quality and outcomes of COVID-19 patients: An open-label, randomized, controlled trial / S. A. Mousavi, K. Heydari, H. Mehravaran, et al. // J Med Virol. 2022 Jan;94(1): p. 263-271. doi: 10.1002/jmv.27312.Melatonin effects on sleep quality and outcomes of COVID-19 patients: An open-label, randomized, controlled trial / S. A. Mousavi, K. Heydari, H. Mehravaran, et al. // J Med Virol. 2022 Jan;94(1): p. 263-271. doi: 10.1002/jmv.27312.Richter K. Sleep quality and COVID-19 outcomes: the evidence-based lessons in the framework of predictive, preventive and personalised (3P) medicine/ K. Richter, S. Kellner, T. Hillemacher, et al. // EPMA J. 2021 Jun 8;12(2): p.221-241. doi: 10.1007/s13167-021-00245-2Richter K. Sleep quality and COVID-19 outcomes: the evidence-based lessons in the framework of predictive, preventive and personalised (3P) medicine/ K. Richter, S. Kellner, T. Hillemacher, et al. // EPMA J. 2021 Jun 8;12(2): p.221-241. doi: 10.1007/s13167-021-00245-2Rubin R.T. Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects / R.T. Rubin, E.K. Heist, S.S. McGeoy et al. // Arch. Gen. Psychiatry. 1992. Vol. 49. № 7. P. 558–567. DOI: 10.1001/archpsyc.1992.01820070052008Rubin R.T. Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects / R.T. Rubin, E.K. Heist, S.S. McGeoy et al. // Arch. Gen. Psychiatry. 1992. Vol. 49. № 7. P. 558–567. DOI: 10.1001/archpsyc.1992.01820070052008Shneider A. Can melatonin reduce the severity of COVID-19 pandemic? / A. Shneider, A. Kudriavtsev, A. Vakhrusheva // Int Rev Immunol (2020 Apr 29), p. 1-10. doi.org/10.1080/08830185.2020.1756284Shneider A. Can melatonin reduce the severity of COVID-19 pandemic? / A. Shneider, A. Kudriavtsev, A. Vakhrusheva // Int Rev Immunol (2020 Apr 29), p. 1-10. doi.org/10.1080/08830185.2020.1756284Zhang R. COVID-19: Melatonin as a potential adjuvant treatment. / R. Zhang, X. Wang, L. Ni et al. // Life Sci. (2020) 250:11758. doi: 10.1016/j.lfs.2020.117583Zhang R. COVID-19: Melatonin as a potential adjuvant treatment. / R. Zhang, X. Wang, L. Ni et al. // Life Sci. (2020) 250:11758. doi: 10.1016/j.lfs.2020.117583Zambrelli E. Delirium and sleep disturbances in COVID-19: a possible role for melatonin in hospitalized patients? / E. Zambrelli, M. Canevini, O. Gambini, et al. // Sleep Med, 70 (2020 Apr 17), p. 111. doi.org/10.1016/j.sleep.2020.04.006Zambrelli E. Delirium and sleep disturbances in COVID-19: a possible role for melatonin in hospitalized patients? / E. Zambrelli, M. Canevini, O. Gambini, et al. // Sleep Med, 70 (2020 Apr 17), p. 111. doi.org/10.1016/j.sleep.2020.04.006Zhang R. COVID-19: melatonin as a potential adjuvant treatment / R. Zhang, X. Wang, L. Ni, et al. // Life Sci, 250 (2020 Jun 1), p. 1-6. DOI: 10.1016/j.lfs.2020.117583Zhang R. COVID-19: melatonin as a potential adjuvant treatment / R. Zhang, X. Wang, L. Ni, et al. // Life Sci, 250 (2020 Jun 1), p. 1-6. DOI: 10.1016/j.lfs.2020.117583

The authors declare that there are no conflicts of interest present.